A main theory behind the cause of Alzheimer’s disease is the build-up of the protein amyloid-beta in the brain. Researchers from the University of Cincinnati provide evidence suggesting it’s the ...
ScienceAlert on MSN
The cause of Alzheimer's may be coming from within your mouth
In recent years, an increasing number of scientific investigations have backed an alarming hypothesis: Alzheimer's disease ...
The research team of Prof.Sung Hoon Kang and Chi Kyung Kim of the Department of Neurology and Prof.Jae Seon Eo of the Department of Nuclear Medicine, Korea University’s Guro Hospital, confirmed that ...
On July 2, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Alzheimer’s disease. Donanemab, or Kisunla, is the third drug approved to target one of the causes of ...
The small molecule spermine has the potential to stop the toxic build-up of proteins in the brain that characterizes diseases ...
Multiple myeloma and AL amyloidosis are conditions linked to plasma cells in the bone marrow. Multiple myeloma (MM) is a cancer affecting the plasma cells, which are mostly in the bone marrow. MM ...
As transthyretin amyloid cardiomyopathy (ATTR-CM) progresses, it can cause more serious problems with the heart and other parts of the body. Talking with your doctor about how the condition may ...
The outlook for hATTR-PN can vary depending on the genetic mutation involved and how the condition first presents. Newer treatments are helping improve outcomes. hATTR is a rare, hereditary disease. A ...
Voyager Therapeutics is tripling down on its Alzheimer’s disease franchise, this time with a gene therapy aimed at amyloid-beta plaques. The company broke the news on its second-quarter earnings call ...
The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback